Skip to main content

Myotonic Dystrophy

Disease Mechanism, Current Management and Therapeutic Development

  • Book
  • © 2018

Overview

  • Provides an overview while also connecting clinical and fundamental research achievements

  • Introduces the molecular mechanisms within each organ and the resultant clinical features, especially focusing on central nervous system

  • Addresses the latest topics such as research using patient-derived iPS cells and therapeutic research

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

Keywords

About this book

This book provides an essential overview combining both clinical and fundamental research advances in myotonic dystrophy. The pathomechanism of myotonic dystrophy has long been unclear, but in the past decade, our understanding has shifted to a novel disease mechanism concept: “RNA disease”. Parallel to these advances in elucidating the pathophysiology, translational research is also progressing rapidly. The current challenge lies in assessing the effectiveness of treatment, and as such, there is a growing interest in observational studies of the disease’s various clinical symptoms.

The book introduces readers to the molecular mechanisms within each organ and the resultant clinical features, which are presented together. In particular, it focuses on the central nervous system, since the pathology of the brain (central nervous system manifestation) has rarely been addressed systematically and will pose a persistent challenge, even if therapies have greatly advanced in the future. In addition, the book addresses the latest developments, such as research using patient-derived iPS cells and therapeutic research.

Myotonic Dystrophy provides essential information for neurologists and researchers with an interest in muscle disease, including muscular dystrophy. Furthermore, since the disease involves various complications of the brain, heart, metabolism, etc., the book will be of great value to clinicians and researchers in the cardiovascular sciences, endocrinology, diabetes, dementia, and neuropsychology, as well as genetic specialists.

Reviews

“This book is suitable for neuromuscular medicine subspecialists, healthcare providers involved in the care of myotonic dystrophy patients, and clinical basic science researchers. The book meets the needs of this audience. … This book stands out as an excellent reference on myotonic dystrophy.” (Eduardo De Sousa, Doody's Book Reviews, June 28, 2019)

Editors and Affiliations

  • Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Osaka, Japan

    Masanori P. Takahashi

  • Department of Neurology, National Hospital Organization Toneyama National Hospital, Osaka, Japan

    Tsuyoshi Matsumura

About the editors

Masanori P. Takahashi, M.D., Ph.D.

Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Japan

Tsuyoshi Matsumura, M.D., Ph.D.

Department of Neurology, National Hospital Organization Toneyama National Hospital, Japan


Bibliographic Information

  • Book Title: Myotonic Dystrophy

  • Book Subtitle: Disease Mechanism, Current Management and Therapeutic Development

  • Editors: Masanori P. Takahashi, Tsuyoshi Matsumura

  • DOI: https://doi.org/10.1007/978-981-13-0508-5

  • Publisher: Springer Singapore

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Singapore Pte Ltd. 2018

  • Hardcover ISBN: 978-981-13-0507-8Published: 12 November 2018

  • Softcover ISBN: 978-981-13-4436-7Published: 29 December 2018

  • eBook ISBN: 978-981-13-0508-5Published: 31 October 2018

  • Edition Number: 1

  • Number of Pages: VIII, 214

  • Number of Illustrations: 16 b/w illustrations, 42 illustrations in colour

  • Topics: Neurology, Cardiology, Metabolic Diseases, Human Genetics

Publish with us